Zyvox (Linezolid) Special Investigation For Vancomycin-Resistant Enterococci (VRE)
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
To collect the efficacy and safety information in subjects who have been treated with Zyvox
(linezolid) for vancomycin resistance Enterococcus faecium infection for their appropriate
use in daily practice.